Anbio Biotechnology (NNNN) Enterprise Value (2023 - 2025)
Anbio Biotechnology has reported Enterprise Value over the past 3 years, most recently at -$11.9 million for Q4 2025.
- Quarterly results put Enterprise Value at -$11.9 million for Q4 2025, down 1.19% from a year ago — trailing twelve months through Dec 2025 was -$11.9 million (down 1.19% YoY), and the annual figure for FY2025 was -$11.9 million, down 1.19%.
- Enterprise Value for Q4 2025 was -$11.9 million at Anbio Biotechnology, down from -$11.8 million in the prior quarter.
- Over the last five years, Enterprise Value for NNNN hit a ceiling of -$9.7 million in Q4 2023 and a floor of -$11.9 million in Q4 2025.
- Median Enterprise Value over the past 3 years was -$11.8 million (2024), compared with a mean of -$11.1 million.
- Biggest five-year swings in Enterprise Value: dropped 21.36% in 2024 and later decreased 1.19% in 2025.
- Anbio Biotechnology's Enterprise Value stood at -$9.7 million in 2023, then dropped by 21.36% to -$11.8 million in 2024, then fell by 1.19% to -$11.9 million in 2025.
- The last three reported values for Enterprise Value were -$11.9 million (Q4 2025), -$11.8 million (Q4 2024), and -$9.7 million (Q4 2023) per Business Quant data.